Exact Mass: 604.197858
Exact Mass Matches: 604.197858
Found 88 metabolites which its exact mass value is equals to given mass value 604.197858
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ferrocytochrome
C33H32FeN4O4 (604.1772821999999)
Ferricytochrome is a cytochrome containing reduced (ferrous) iron. Cytochrome c is an electron-carrying protein found in mitochondria of all aerobic organisms. It is part of the terminal oxidation chain, which completes the breakdown of foods to COZ and HzO, storing the liberated chemical energy in molecules of ATP. Like myoglobin, it is an iron porphyrin protein, made up of one heme group and one polypeptide chain. The iron atomalternates between the +2 and +3 oxidation state as the molecule interacts in turn with cytochrome reductase and cytochrome oxidase, each a large multimolecular complex (l-3). One of the goals of the present x-ray analysis is to understand how electron. transfer occurs into and out of cytochrome c, which will ultimately require a knowledge of the molecular structure in both the ferric and ferrous states. Ferricytochrome is a cytochrome containing reduced (ferrous) iron.
Modipafant
N-[4-[[3-[(1-Ethyl-3-fluoropiperidin-4-yl)amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide
[(1S,4aS,6S,7R,7aS)-6-acetyloxy-4-[[(2R,3R,4S,5S,6R)-3-acetyloxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-7-(acetyloxymethyl)-7-hydroxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-1-yl] 3-methylbutanoate
Daphnetoxin, 12-(benzoyloxy)-1,2-dihydro-, (12-beta)-
kadsuphilol U|rel-(5R,6R,7R,8S,14aR)-5-(acetyloxy)-5,6,7,8-tetrahydro-6-hydroxy-2,3-dimethoxy-6,7-dimethyl-1-oxo-1H,14H-10,12,13-trioxabenzo[1,8]cyclooct[1,2,3-cd]-as-indacen-8-yl (2E)-3-phenylprop-2-enoate
(1R,2S,4S,5S,6R,7R,9S,10S)-9-benzoyloxy-1,2,6,15-tetra-acetoxy-4-hydroxy-8-oxo-dihydro-beta-agarofuran
bis-5,6-dihydro-2(1H)-pyridonyl-trans-trans-trans-2-(2,4-dimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,3-cyclobutanedicarboxamide|piperarborenine D
kadsuphilol V|rel-(5R,6R,7R,8S,14aR)-5-(acetyloxy)-5,6,7,8-tetrahydro-6-hydroxy-1,2-dimethoxy-6,7-dimethyl-3-oxo-3H,14H-10,12,13-trioxabenzo[1,8]cyclooct[1,2,3-cd]-as-indacen-8-yl (2E)-3-phenylprop-2-enoate
6?-O-p-hydroxybenzoyl-6-O-p-hydroxybenzoyl-5,7-bisdeoxycynanchoside
Dehydrobruceantinol
3-O-[(E)-3,4,5-trimethoxycinnamoyl]-beta-D-fructofuranosyl-(2->1)-(6-O-acetyl)-alpha-D-glucopyranoside|tricornose A
kaempferol 3-O-alpha-L-(4-O-acetyl)rhamnopyranoside-7-O-alpha-L-rhamnopyranoside|sutchuenoside A
1alpha,8alpha-oxido-3beta-acetoxy-2alpha-acelperoxy-1alpha,14alpha-dihydroxy-[3.3.110,2]-bicyclomeliac-7,19-olide
[(1S,4aS,6S,7R,7aS)-6-acetyloxy-4-[[(2R,3R,4S,5S,6R)-3-acetyloxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-7-(acetyloxymethyl)-7-hydroxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-1-yl] 3-methylbutanoate_major
Glu Met Tyr Tyr
Glu Tyr Met Tyr
Glu Tyr Tyr Met
Met Glu Tyr Tyr
Met Tyr Glu Tyr
Met Tyr Tyr Glu
Tyr Glu Met Tyr
Tyr Glu Tyr Met
Tyr Met Glu Tyr
Tyr Met Tyr Glu
Tyr Tyr Glu Met
Tyr Tyr Met Glu
Hp 5B
1-Benzoyl-4-[4-(1,1-dimethylpropyl)phenoxy]-6-(phenylamino)-3H-dibenz[f,ij]isoquinoline-2,7-dione
Oxantel pamoate
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
(-)-1,2-Bis[(2R,5R)-dimethylphospholano]benzene(cyclooctadiene)rhodium(I) tetrafluoroborate
N,N-BIS[O-(DIPHENYLPHOSPHINO)BENZYLIDENE]ETHYLENEDIAMINE
O-Allyl-N-(9-anthracenylmethyl)cinchonidinium bromide
(1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyltriacetate
O-methyl-4-O-[alpha-L-fucopyranosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->3)-2-O-methyl-alpha-L-rhamnopyranosyl]-hydroxybenzoate
3-[(21S,22S)-11,16-bis(ethenyl)-12-formyl-4-hydroxy-3-methoxycarbonyl-17,21,26-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
alpha-D-GlcpA4Me-(1->2)-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-beta-D-Xylp
[(3S,4S)-10-hydroxy-5-[(3S)-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-4-yl] acetate
N-[[(4R,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4R,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4S,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4R,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4S,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4S,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[(5S,6R,9R)-8-(3-chlorophenyl)sulfonyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
C28H33ClN4O7S (604.1758378000001)
N-[[(4R,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4S,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
1-(2-fluorophenyl)-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2,2,2-trifluoroethylsulfonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(2S,3S,4R,5R,6S)-4,5-dihydroxy-6-[(2S,3R,4S,5R)-4-hydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(3R,4R,5R,6R)-4,5,6-trihydroxyoxan-3-yl]oxyoxan-3-yl]oxy-3-methoxyoxane-2-carboxylic acid
IPN60090 (dihydrochloride)
IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1?(GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 dihydrochloride can be used for solid tumors research, such as lung and ovarian cancers[1][2].
6-(hydroxymethyl)-1,6-dimethyl-7h,8h,9h-phenanthro[1,2-b]furan-10,11-dione; tanshinone iia
(3s,4s)-2-[(2s)-1-amino-6-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}hexan-2-yl]-3,7,8-trihydroxy-4-(1h-indol-3-yl)-1-oxo-4h-isoquinoline-3-carboxylic acid
(2s,3s,4r,5r,6s)-6-{[(2s,3r,4s,5r)-2-{[(3r,4r,5r,6s)-4,5-dihydroxy-6-{[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl]oxy}-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid
2-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-4-hydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate
2-[(5-carbamimidamido-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1-hydroxypentylidene)amino]-5-[n-(2,3-dihydroxybenzoyloxy)formamido]pentanoic acid
C26H32N6O11 (604.2128961999999)